Niche leadership NovaSterilis leads in scCO2 processes for biomaterials and medical devices, offering a unique sterilization and decellularization capability that can differentiate potential buyers’ products in orthopedics, dental, and spinal markets.

Temperature sensitive advantages The low temperature (31°C) and high-pressure scCO2 approach preserves delicate materials and structural/chemical integrity, creating a compelling value proposition for manufacturers of temperature-sensitive allografts, xenografts, and other biologics seeking gentle sterilization.

Speed and safety With a stated sterility assurance level of 10-6 and shorter turnaround times, NovaSterilis can help medical device and tissue products reach market faster while maintaining strict safety standards, addressing time-to-market pressures for customers.

Diverse market reach Serving complex medical devices, drug delivery, tissue engineering, biotherapeutics, and additive manufacturing, the company offers cross-market applicability, enabling sales teams to target multiple segments with a single scalable technology.

Strategic engagement Recent participation in the European Society for Biomaterials conference signals active thought leadership and opportunities to connect with potential collaborators, partners, and customers at industry events.